Evommune, Inc. SEC EDGAR Filings (CIK 0002044725)

SEC EDGAR filings, ownership reports, and insider transactions for Evommune, Inc..

Symbol
EVMN on NYSE
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
1841 Page Mill Rd, Palo Alto, CA, 94304
State of incorporation
DE
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Evommune, Inc. has filed 65 SEC EDGAR filings since 07 Jan 2025

Latest Filings

Recent SEC filings for Evommune, Inc. including 4, 10-Q, 8-K and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 22 Dec 2025 19 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 19 Dec 2025 08 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Dec 2025 09 Dec 2025
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 11 Dec 2025 30 Sep 2025 001-42938
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 11 Dec 2025 11 Dec 2025 001-42938
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 17 Nov 2025 005-95351
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 17 Nov 2025 005-95351
SCHEDULE 13D Open SCHEDULE 13D document View SEC filing for SCHEDULE 13D 14 Nov 2025 005-95351
4 Open 4 document View SEC filing for 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
4 Open 4 document View SEC filing for 4 12 Nov 2025 07 Nov 2025
S-8 Open S-8 document | Open XBRL data View SEC filing for S-8 S-8 07 Nov 2025 333-291386
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
4 Open 4 document View SEC filing for 4 07 Nov 2025 05 Nov 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 07 Nov 2025 07 Nov 2025 001-42938
424B4 Open 424B4 document View SEC filing for 424B4 424B4 06 Nov 2025 333-290793
FWP Open FWP document View SEC filing for FWP FWP 06 Nov 2025 333-290793
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
3 Open 3 document View SEC filing for 3 05 Nov 2025 05 Nov 2025
CERT Open CERT document View SEC filing for CERT NYSE CERTIFICATION 05 Nov 2025 001-42938
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 04 Nov 2025 001-42938
FWP Open FWP document View SEC filing for FWP FWP 30 Oct 2025 333-290793
S-1/A Open S-1/A document | Open XBRL data View SEC filing for S-1/A S-1/A 17 Oct 2025 333-290793
S-1 Open S-1 document | Open XBRL data View SEC filing for S-1 S-1 09 Oct 2025 333-290793
DRS/A Open DRS/A document View SEC filing for DRS/A 23 Sep 2025 377-08010
DRS/A Open DRS/A document View SEC filing for DRS/A 02 Sep 2025 377-08010
DRS/A Open DRS/A document View SEC filing for DRS/A 18 Jul 2025 377-08010
DRS Open DRS document View SEC filing for DRS 14 May 2025 377-08010
D Open D document View SEC filing for D 08 Jan 2025 021-534546
D Open D document View SEC filing for D 08 Jan 2025 021-534516
D Open D document View SEC filing for D 08 Jan 2025 021-534510
D Open D document View SEC filing for D 07 Jan 2025 021-534380

About this filer

Evommune, Inc. files with the SEC under CIK 0002044725. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages